Keyphrases
Antibody Detection
33%
Antigen Processing
20%
Antigen-specific
14%
Autoantibodies
70%
Autoantibody Biomarker
20%
Bead Array
19%
Breast Cancer
100%
Cancer Patients
20%
Carbohydrate Antigen 125 (CA125)
22%
CD8+ T Cells
16%
Cervical Cancer
22%
Cytotoxic T Lymphocytes
16%
Early Breast Cancer
17%
Early Detection
38%
Early Disease
19%
Enzyme-linked Immunosorbent Assay (ELISA)
29%
Epitope
33%
Head-and-neck Cancer
15%
Healthy Individuals
22%
High-risk Human Papillomavirus (HR-HPV)
59%
Highly Sensitive
15%
HLA-A2
24%
HPV16
79%
HPV16 E7
16%
Human Telomerase Reverse Transcriptase (hTERT)
26%
Immune Response
34%
Immunogenicity
25%
In Cancer
18%
Janus Kinase 2 (JAK2)
22%
MHC Class II
17%
Multiplex Detection
18%
Multiplexing
22%
Neoepitope
21%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
54%
Ovarian Cancer
45%
Point-of-care
27%
Potential Biomarkers
17%
Prognostic Biomarker
30%
Programmed Death-ligand 1 (PD-L1)
22%
Protein Microarray
36%
Proteomics
17%
Risk Stratification
15%
Serum Antibody
20%
T Cells
31%
Telomerase
18%
Triple-negative Breast Cancer
41%
Tumor
77%
Tumor Antigen
85%
Tumor Cells
18%
Vaccination
22%
Immunology and Microbiology
Allele
11%
Amplicon
12%
Antibodies
8%
Antibody Blood Level
13%
Antigen Presentation
21%
Antigen Specificity
14%
Antigen-Presenting Cell
13%
Autoantibodies
60%
Autoimmunity
11%
B Cell
16%
Bioinformatics
11%
Cancer Immunotherapy
12%
Cell Line
8%
Cell Mutant
12%
Cytokine
13%
Cytotoxic T Cell
28%
Cytotoxic T-Cell
26%
Dendritic Cell
9%
Early Antigen
9%
ELISA
23%
Enzyme-Linked Immunosorbent Assay
18%
Epidermal Growth Factor
10%
Epitope
79%
Human Papillomavirus Type 16
45%
Humoral Immunity
14%
Hydrophobicity
7%
Immune Response
35%
Immune System
8%
Immunity
40%
Immunogenicity
19%
Immunotherapy
34%
Infectious Agent
9%
MHC Class I
12%
Multiple Myeloma
18%
Neck
14%
P53
22%
Peptides
49%
Protein Microarray
26%
Proteomics
32%
Reverse Transcriptase
12%
Serology
7%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Squamous Cell
11%
T Cell
57%
T Cell Receptor
7%
Tumor Antigen
62%
Tumor Cell
8%
Tumor Vaccine
19%
Virus Antigen
7%
Wart Virus
25%
Medicine and Dentistry
Autoantibodies
41%
Biological Marker
59%
Breast Cancer
93%
Breast Cancer Screening
12%
Breast Carcinoma
8%
Breast Tumor
9%
CA-125
14%
Cancer
14%
Cancer Risk
7%
Cervical Cancer
11%
Clinical Trial
14%
CYP1B1
12%
Cytotoxic T-Cell
8%
Disease Exacerbation
9%
Diseases
37%
Enzyme Linked Immunosorbent Assay
11%
Epitope
17%
Estrogen Receptor
9%
Evolution
12%
Health Care Cost
11%
Human Papillomavirus Type 16
40%
Immune Response
11%
Immunity
8%
Immunoassay
7%
Immunotherapy
9%
Integrin
7%
Malignant Neoplasm
19%
Mammography
15%
Medical Care
9%
Messenger RNA
7%
Metastatic Carcinoma
11%
Multiple Myeloma
12%
Neoadjuvant Therapy
12%
Neoplasm
53%
Oropharynx Carcinoma
29%
Ovarian Cancer
36%
Penis Cancer
7%
Prevalence
12%
Prospective Study
7%
Protein Microarray
16%
Protein P53
12%
Proteomics
7%
Public Health
9%
Recurrent Disease
9%
Sentinel Lymph Node Biopsy
13%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
T Cell
11%
Triple Negative Breast Cancer
19%
Tumor Antigen
25%
Wart Virus
32%